PDRN Dosing Guide: What Concentrations Work Best for Skin Rejuvenation in Indian Skin
- Ankit Singla
- 5 hours ago
- 6 min read
By NW Aesthetics | Clinical Reference for Dermatologists & Aesthetic Physicians
One of the most common questions dermatologists ask before adding PDRN to their practice is not whether it works — the clinical evidence for that is well-established — but how much to use, at what concentration, and how often.
The answer depends significantly on the product you are using. Not all PDRN formulations are equal. This guide uses NucleoSkin — a triple-action Italian pharmaceutical-grade injectable — as the clinical reference, and explains how its formulation translates into precise, zone-specific dosing decisions.
Why Concentration and Molecular Weight Matter More Than Most Doctors Realise
PDRN products are characterised by three variables that determine clinical effect:
1. Concentration (mg/ml) Most commercial PDRN products range from 3–10 mg/ml. NucleoSkin contains PDRN at 20 mg/ml — significantly higher than most products in the market. At this concentration, the biological stimulus per ml is substantially greater, which means effective results are achieved at lower injection volumes per zone.
2. Molecular Weight (kDa) Higher molecular weight PDRN fractions (above 2,000 kDa) have stronger affinity for the A2A adenosine receptor — the primary mechanism through which PDRN drives fibroblast proliferation, collagen synthesis, and VEGF-mediated angiogenesis. NucleoSkin uses 2,500 kDa PDRN, placing it in the high molecular weight category with strong receptor-binding activity.
3. Purity Grade Pharmaceutical-grade PDRN undergoes enzymatic hydrolysis and rigorous purification to remove proteins, lipids, and immunogenic material from the salmon DNA source. NucleoSkin is manufactured in Italy to pharmaceutical standards — this is what separates it from lower-grade cosmetic preparations available in the market.
Key clinical takeaway: When evaluating PDRN products, do not look at concentration alone. A 20 mg/ml high-molecular-weight pharmaceutical-grade PDRN will deliver a fundamentally different clinical response than a 4 mg/ml cosmetic-grade product — even at the same injection volume.
NucleoSkin: A Triple-Action Formulation
Most PDRN products on the market contain PDRN as a standalone active. NucleoSkin is formulated as a three-component regenerative injectable:
Component | Concentration | Primary Role |
PDRN | 20 mg/ml (2,500 kDa) | Tissue regeneration, collagen synthesis, angiogenesis |
Hyaluronic Acid | 10 mg/ml | Dermal hydration, extracellular matrix support |
Glutathione | 2 mg/ml | Skin brightening, antioxidant protection, tyrosinase inhibition |
This combination is clinically significant. The HA component creates a hydrated extracellular matrix that facilitates PDRN diffusion and receptor binding. The Glutathione component adds a brightening and antioxidant dimension — particularly relevant for Indian skin where pigmentation concerns frequently co-exist with ageing and scarring indications.
The result is a single injectable that simultaneously addresses regeneration, hydration, and radiance.
Zone-by-Zone Dosing Protocol for NucleoSkin
Because NucleoSkin operates at 20 mg/ml — approximately 3–5x the concentration of standard PDRN products — effective clinical results are achieved at precise, lower volumes per zone. The protocol below reflects real-world clinical use.
Cheeks
The cheeks are the primary treatment zone for facial rejuvenation — addressing skin laxity, fine lines, and overall skin quality.
Parameter | Recommendation |
Volume | 1–2 ml per side |
Practical note | 1–1.5 ml per side delivers good results; 2 ml per side for patients seeking maximum effect |
Injection depth | 2-3 mm (intradermal) |
Technique | Nappage or serial microinjections |
Session frequency | Every 3 weeks |
Induction course | 4 sessions |
Maintenance | Every 4–6 weeks |
Clinical note: The flexibility in volume (1–2 ml per side) makes this easy to structure across patient budgets — a 2 ml per side session is a premium protocol; 1–1.5 ml per side still delivers clinically meaningful improvement and is a good entry point for new PDRN patients. The Glutathione component improves skin radiance from session 2 onwards, which drives patient satisfaction and retention.
Periorbital (Under-Eye)
The periorbital zone demands precision — thin skin, proximity to the orbicularis, and high patient sensitivity. NucleoSkin is diluted here to ensure smooth superficial delivery.
Parameter | Recommendation |
Volume | 1 ml NucleoSkin diluted with saline (1:1) → 2 ml total |
Injection depth | 0.5–1 mm (very superficial intradermal) |
Technique | Fine papules, 30G–32G needle |
Session frequency | Every 3 weeks |
Induction course | 3–4 sessions |
Clinical note: Dilution with saline at 1:1 ratio allows precise superficial delivery without the resistance of undiluted product in this delicate zone. The Glutathione in NucleoSkin adds a brightening benefit to the periorbital area — particularly valuable for patients presenting with pigmented dark circles alongside skin quality concerns.
Forehead
The forehead is treated conservatively — lower volumes, diluted product, superficial delivery.
Parameter | Recommendation |
Volume | 0.5 ml NucleoSkin diluted with saline |
Injection depth | 1–1.5 mm (intradermal) |
Technique | Serial microinjections or nappage |
Session frequency | Every 3 weeks |
Induction course | 3 sessions |
Clinical note: The forehead often shows fine lines and early laxity that respond well to PDRN's collagen-stimulating effect. Dilution allows wider coverage of the zone with controlled delivery.
Neck
The neck is a high-concern area for patients above 40 — thin, chronically photoaged skin with horizontal necklace lines and early crepiness.
Parameter | Recommendation |
Volume | 2 ml (undiluted) |
Injection depth | 1–1.5 mm (intradermal) |
Technique | Wide-area nappage |
Session frequency | Every 3 weeks |
Induction course | 3 sessions |
Clinical note: The neck requires adequate volume to cover the treatment surface. At 20 mg/ml, 2 ml of NucleoSkin still delivers a highly concentrated regenerative dose across the full neck zone. Document with standardised photography — neck improvement is often striking and builds strong word-of-mouth referrals.
Hands
Hands are one of the most visible signs of ageing and one of the most underserved areas in Indian aesthetic clinics — a clear opportunity for practices looking to differentiate.
Parameter | Recommendation |
Volume | 1 ml per hand |
Injection depth | 1–1.5 mm (intradermal dorsum) |
Technique | Serial microinjections or nappage over dorsum |
Session frequency | Every 3 weeks |
Induction course | 4 sessions |
Clinical note: At 1 ml per hand, the treatment is economical and quick to administer. The HA component in NucleoSkin provides immediate hydration and skin plumping on the dorsum, while PDRN addresses longer-term skin quality improvement. Pair with sunscreen counselling — hands are chronically sun-exposed and will revert faster without photoprotection.
Melasma and Pigmentation
Pigmentation treatment with NucleoSkin leverages the Glutathione component (tyrosinase inhibition) alongside PDRN's anti-inflammatory and tissue repair properties. Volume is area-dependent rather than zone-standardised.
Parameter | Recommendation |
Volume | 0.5–1 ml directly into the pigmented area |
Injection depth | 1–2 mm (intradermal, targeting the pigmented zone) |
Technique | Serial microinjections confined to the pigmentation boundary |
Session frequency | Every 3 weeks |
Induction course | 4–6 sessions depending on severity |
Clinical note: This is where NucleoSkin's triple-action formulation genuinely differentiates from plain PDRN. The Glutathione works on melanin synthesis inhibition while PDRN reduces dermal inflammation — a known driver of melasma. Ideal for refractory melasma cases where topical agents have plateaued. Combine with strict sun avoidance and daily broad-spectrum SPF 50+ as a non-negotiable adjunct.
A Note on Dilution
NucleoSkin at 20 mg/ml is used undiluted for most zones. Dilution with saline is recommended only for the periorbital and forehead zones, where superficial delivery precision and lower resistance are clinically advantageous.
Dilution protocol when required:
Diluent: Normal saline (0.9% NaCl) only — never sterile water (hypotonic, causes tissue irritation)
Ratio: 1:1 (NucleoSkin:saline)
Result: 10 mg/ml PDRN, 5 mg/ml HA, 1 mg/ml Glutathione — still therapeutically active concentrations
Do not dilute for cheeks, neck, hands — these zones benefit from the full 20 mg/ml concentration.
Combination Sequencing: NucleoSkin with Other Treatments
Combination | Protocol |
NucleoSkin + PRP | PRP first (subdermal), NucleoSkin second (intradermal). Same session, different planes. |
NucleoSkin + HA Skin Booster | Separate sessions — NucleoSkin week 1, HA filler week 3. NucleoSkin's own HA component handles interim hydration. |
NucleoSkin + Microneedling | Use NucleoSkin as topical infusion during needling — open channels maximise transdermal delivery of PDRN and Glutathione. |
NucleoSkin + CO2 / Fractional Laser | 1–2 ml NucleoSkin over treated area, 48–72 hours post-procedure. Accelerates recovery and enhances final result. |
Dosing Frequency: The Biological Rationale for Spacing
Too frequent (under 10 days apart): Fibroblast fatigue — repeated stimulation blunts the response. Increased bruising and oedema.
Too infrequent (beyond 4 weeks in induction phase): Regenerative stimulus fades before the next session reinforces it. Collagen remodelling cycle is interrupted.
The 3-week interval for the induction phase is the evidence-based standard for most indications. For more sensitive zones (periorbital, forehead) or combination protocols, 3 weeks is appropriate.
Quick Reference: NucleoSkin Zone Dosing Summary
Zone | Volume | Dilution | Depth | Frequency | Induction |
Cheeks | 1–2 ml per side | No | 2-3 mm | Every 2 weeks | 4 sessions |
Periorbital | 1 ml + saline (1:1) | Yes | 0.5–1 mm | Every 3 weeks | 3–4 sessions |
Forehead | 0.5 ml + saline | Yes | 1–1.5 mm | Every 2–3 weeks | 4 sessions |
Neck | 2 ml | No | 2–2.5 mm | Every 3 weeks | 4 sessions |
Hands | 1 ml per hand | No | 1–1.5 mm | Every 3 weeks | 4 sessions |
Melasma / Pigmentation | 0.5–1 ml (area dependent) | No | 1–2 mm | Every 2–3 weeks | 4–6 sessions |
Conclusion
Precision dosing is what separates good outcomes from exceptional ones. NucleoSkin's high-concentration triple-action formulation — PDRN 20 mg/ml at 2,500 kDa, combined with HA and Glutathione — means you are delivering regeneration, hydration, and brightening in a single injectable, at volumes precisely calibrated to each facial and body zone.
For protocol cards, clinical data sheets, or to arrange a NucleoSkin introductory training session for your clinic team, contact NW Aesthetics.
NW Aesthetics is a pan-India distributor of premium European aesthetic medicine. Our portfolio includes NucleoSkin (PDRN + HA + Glutathione), AQ Skin Solutions Hair Complex, Pink Intimate System, and MShape multi-energy body contouring.
For clinical enquiries: Contact us
Comments